Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07597603 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Unconscious Mind Training

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Site details revised
    • Publications: details revised at 5 of 6 entries
    • Eligibility criteria expanded, about 2 words
  2. Notable Recruitment opened
    • Start date: Jan 2027 to Jul 2027
    • Study sites: 0 to 1
    v4
  3. Minor Collaborators expanded, about 3 wordsv3
  4. Minor Study description expanded, about 248 wordsv2
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
H22 - Unconscious Mind Training and Memory Encoding Phase 2.1 in progress. The core problem this clinical trial, H22, seeks to address is the pervasive challenge of modifying deeply ingrained, often unconscious, unwanted behaviors within the general population. Many individuals struggle with habits or actions that negatively impact quality of life, productivity, or well-being, yet conventional methods often fall short due to the unconscious nature of these behaviors. Specifically, the trial aims to investigate the efficacy of H22, a novel intervention designed to engage and train the unconscious mind, in mitigating these unwanted behaviors. The central hypothesis guiding this research is that H22 training will empower volunteers to significantly reduce the frequency and intensity of identified unwanted behaviors. Phase 1 Results: The trial took place in Shagamu, Nigeria, between July 25, 2026, and August 7, 2026. The study monitored 20 participants over a 14-day intervention period, evaluating their baseline assessment scores, end-of-week progress across Weeks 1 and 2, and their decisions regarding whether to continue integrating Study H22 into daily life. All 20 enrolled participants completed the full 14 days, yielding a 100% study retention rate. Participant scores improved significantly over the 14 days, increasing from a baseline average of 14.37 to 63.00 at Week 1, and reaching 99.40 by Week 2. At the conclusion of the trial, 85% of participants (17 of 20) chose to continue Study H22 in daily life.
Trial Details
NCT Number NCT07597603
Lead Sponsor Dream Video LLC
Collaborators: Dream Holdings Research
Conditions
(from sponsor)
Memory Encoding, Memory, Behavior Change Interventions, Habits
Related terms Behavior, Habits
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov